Shanghai Pharmaceuticals Holding Co., Ltd. announced the personnel changes in relation to the Board, the board of supervisors and management of the Company. Mr. ZHOU Jie, an executive director, has been elected by the Board as the chairman of the sixth session of the Board for a term for three years, with effect from 28 June 2016. Mr. XU Youli, a supervisor, has been elected by the board of supervisors as the chief supervisor of the sixth session of the board of supervisors for a term for three years, with effect from 28 June 2016.

Mr. CHO Man, an executive director, has been elected by the Board as the convener of the Strategy Committee of the Board; Mr. TSE Cho Che, Edward, an independent non-executive director, and Mr. CAI Jiangnan, an independent non-executive director, have been elected by the Board as members of the Strategy Committee of the Board. Mr. TSE Cho Che, Edward, an independent non-executive director, has been elected by the Board as the convener of the Nomination Committee of the Board; Mr. ZHOU Jie, an executive director, and Mr. HONG Liang, an independent non-executive director, have been elected by the Board as members of the Nomination Committee of the Board. Mr. WAN Kam To, an independent non-executive director, has been elected by the Board as the convener of the Audit Committee of the Board; Mr. TSE Cho Che, Edward, an independent non-executive director, and Mr. HONG Liang, an independent non-executive director, have been elected by the Board as members of the Audit Committee of the Board.

Mr. HONG Liang, an independent non-executive director, has been elected by the Board as the convener of the Remuneration and Assessment Committee of the Board; Mr. WAN Kam To, an independent non-executive director, and Mr. CAI Jiangnan, an independent non-executive director, have been elected by the Board as members of the Remuneration and Assessment Committee of the Board. Mr. CHO Man, an executive director, has been appointed as the president of the Company by the Board for the same term as the sixth session of the Board, with effect from 28 June 2016; and Mr. LIU Yanjun, Mr. REN Jian, Mr. SHU Chang and Mr. MAO Jianyi have been appointed as the vice presidents of the Company, Mr. SHEN Bo has been appointed as the chief financial officer of the Company, and Mr. LIU Dawei has been appointed as the Board secretary and the joint company secretary by the Board, all for the same term as the sixth session of the Board, with effect from 28 June 2016.